Drug Trial Radar · NCT02956772
Transcatheter Arterial Chemoembolization (TACE) in Combination With Arsenic Trioxide Versus TACE in the Treatment of Middle-advanced Primary Hepatocellular Carcinoma (HCC) Patients
Last checked: Nov 20, 2026Latest source record: Feb 23, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
190
Planned (sponsor's estimate)
Start
Nov 2016
Primary completion
Nov 2019
Study completion Nov 2020
Sponsor
- Lead sponsor
- Hunan Provincial People's HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 7, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A multicentre, randomized, open-label, parallel-group, active controlled study.
Conditions
- Primary Hepatocellular Carcinoma
Interventions
TACEDrug
After the puncture of femoral artery via Seldinger method, a catheter was inserted and digital celiac axis or hepatic arteriography performed. Then a microcatheter was used to infuse chemotherapeutic agent (30 to 60 mg of pirarubicin) mixed with 5 to 20 mL of Lipiodol Ultra-Fluid. Embosphere microspheres (size of 100 to 300 um) were inserted for embolization.
Arsenic trioxideDrug
Arsenic trioxide 10 mg is put into 500 ml saline solution and then administrated by continuous intravenous drip for 5 hours during a treatment day.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression free survivalTime frame: 2-year
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
Guizhou Cancer Hospital
Guiyang, Guizhou, China
Guizhou Province Tumor Hospital
Guiyang, Guizhou, China
Hunan Provincial People's Hospital
Changsha, Hunan, China
Hunan Cancer Hospital
Changsha, Hunan, China
Xiangya Hospital Central South University
Changsha, Hunan, China
The First Affiliated Hospital of University of South China
Hengyang, Hunan, China
Jiangsu Province Hospital
Nanjing, Jiangsu, China
Xinjiang Medical University Cancer Hospital
Ürümqi, Xinjiang, China
The Tumor Hospital of Yunnan Province
Kunming, Yunnan, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.